• Abintus Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference

    14 days ago - By San Diego Biotechnology

    SAN DIEGO--Abintus Bio, Inc. , a company pioneering first-in-class, off-the-shelf medicines that reprogram cells directly in vivo, today announced its participation in the 40th Annual J.P. Morgan Healthcare Conference. Nicholas Boyle, Ph.D., Co-Founder, President and Chief Executive Officer, will present an overview of the company on January 13, 2022,...
    Read more ...